For investors seeking momentum, iShares U.S. Healthcare ETF IYH is probably on the radar. The fund just hit a 52-week high and has risen 23.24% from its 52-week low of $53.35 per share.
But, are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook to get a better idea of where it might head:
IYH in Focus
The underlying Russell 1000 Health Care RIC 22.5/45 Capped Gross Index measures the performance of the healthcare sector of the U.S. equity market. The product charges 38 bps in annual fees (See: All Health Care ETFs).
Why the Move?
Healthcare has picked up momentum lately, with investors seeking safety amid growing worries about AI overvaluation. The fund has allocated about 14.60% to Eli Lilly LLY, which briefly surpassed the $1 trillion market cap mark on Nov. 21, making it the first healthcare company to break into a club long ruled by tech heavyweights.
Additionally, the increasing adoption of AI in U.S. healthcare continues to provide a meaningful tailwind for the sector.
More Gains Ahead?
Currently, IYH has a Zacks ETF Rank #3 (Hold) with a High risk outlook. However, it might continue its strong performance in the near term, with a positive weighted alpha of 11.59 (as per Barchart.com), which gives cues of a further rally.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Eli Lilly and Company (LLY): Free Stock Analysis Report iShares U.S. Healthcare ETF (IYH): ETF Research ReportsThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
